Showing results (271-280 of 296) with videos related to
Sort By:
Pageof 30
American Heart Journal|May 5, 2021
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trialChristian Zanchin, Konstantinos C Koskinas, Yasushi Ueki, et al.JAMA|April 3, 2022
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical TrialLorenz Räber, Yasushi Ueki, Tatsuhiko Otsuka, et al.BMJ (Clinical Research Ed.)|September 29, 2016
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trialSergio Leonardi, Enrico Frigoli, Martina Rothenbühler, et al.Journal of the American College of Cardiology|September 1, 2022
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial InfarctionBarbara E Stähli, Roland Klingenberg, Dik Heg, et al.Journal of the American College of Cardiology|August 18, 2022
Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet TherapyMarco Valgimigli, Enrico Frigoli, Pascal Vranckx, et al.Circulation|August 30, 2021
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled TrialPieter C Smits, Enrico Frigoli, Jan Tijssen, et al.Journal of the American College of Cardiology|September 22, 2022
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding RiskPieter C Smits, Enrico Frigoli, Pascal Vranckx, et al.Journal of the American College of Cardiology|May 23, 2017
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIXGiuseppe Andò, Bernardo Cortese, Filippo Russo, et al.BMJ (Clinical Research Ed.)|June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trialsMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.Journal of the American College of Cardiology|February 8, 2023
P2Y<sub>12</sub> Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary InterventionsFelice Gragnano, Roxana Mehran, Mattia Branca, et al.Pageof 30